当前位置: 首页 > 期刊 > 《中国医药导报》 > 2020年第5期
编号:1355626
中性粒细胞/淋巴细胞比值在细菌性肺炎中的应用进展
http://www.100md.com 2020年4月2日 中国医药导报 2020年第5期
     卢水焕 刘学员 朱中权

    [摘要] 中性粒细胞/淋巴细胞比值(NLR)已成为公认的全身炎性反应的有效指标之一。越来越多的证据显示NLR是一个简便实用的检测指标,可以准确诊断细菌性肺炎及评估患者的病情严重程度和预后,对于区分不同致病菌也有一定价值,尤其对于基层医院具有普及的临床应用意义。本文从NLR在细菌性肺炎诊断、病情及预后评估等方面的作用价值进行综述,旨在为NLR的临床应用提供依据和参考。

    [关键词] 肺炎;中性粒细胞与淋巴细胞比值;诊断;预后

    [中图分类号] R691.3? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-7210(2020)02(b)-0035-04

    Progress on the application of neutrophil/lymphocyte ratio in bacterial pneumonia

    LU Shuihuan1? ?LIU Xueyuan1? ?ZHU Zhongquan2

    1.Department of Geriatrics, No. 924 Hospital of People′s Liberation Army of China, Guangxi Zhuang Autonomous Region, Guilin? ?541002, China; 2.Department of Cardiothoracic Surgery, No. 924 Hospital of People′s Liberation Army of China, Guangxi Zhuang Autonomous Region, Guilin? ?541002, China

    [Abstract] The neutrophil/lymphocyte ratio (NLR) has become one of the recognized effective indicators of systemic inflammatory response. More and more evidence shows that NLR is a simple and practical index which can accurately diagnose bacterial pneumonia and evaluate the severity and prognosis of patients. It is also valuable to distinguish different pathogens. So it especially has universal clinical significance for primary hospitals. This article reviews the role of NLR in the diagnosis ......

您现在查看是摘要页,全文长 11707 字符